On June 22, BeOne Medicines (06160.HK) fell 3.05% in regular trading, trading at 157.2 HKD/share, with turnover of 107 million HKD.
Within the Biotechnology sector where BeOne Medicines belongs, the overall sector is under broad selling pressure. Among individual stocks, AKESO down 7.48%, SKB BIO down 6.25%, REMEGEN down 6.13%, 3SBIO down 4.74%, INNOVENT BIO down 4.66%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)